Evidence map›Paper›PMID 40112252›Full record

ArticlePloS one2025

Predictors of interruptions in antiretroviral therapy among people living with HIV in Nigeria: a retrospective cohort study using the Nigeria national data repository.

Sunday Ikakke Ikpe, Bashorun Ade, Aliyu Gambo, Rebecca Nowak, John D Sorkin, Manhattan Charurat, Timothy O'Connor, Kristen Stafford

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sunday Ikakke IkpeUniversity of Maryland Baltimore School of Medicine, Baltimore, Maryland, United States of America.ORCID 0000-0001-9036-4526
Bashorun AdeFederal Ministry of Health, Nigeria.
Aliyu GamboNigeria AIDS Control Agency, Abuja, Nigeria.
Rebecca NowakUniversity of Maryland Baltimore School of Medicine, Baltimore, Maryland, United States of America.ORCID 0000-0001-8404-4569
John D SorkinBaltimore V.A. Medical Center Geriatric Research, Education and Clinical Center.
Manhattan CharuratUniversity of Maryland Baltimore School of Medicine, Baltimore, Maryland, United States of America.
Timothy O'ConnorUniversity of Maryland Baltimore School of Medicine, Baltimore, Maryland, United States of America.
Kristen StaffordUniversity of Maryland Baltimore School of Medicine, Baltimore, Maryland, United States of America.ORCID 0000-0001-5620-6436

Funding

University of Maryland Claude D. Pepper Older Americans Independence Center (UM-OAIC)P30AG028747 · NIA · UNIVERSITY OF MARYLAND BALTIMORE · PI ALICE S. RYAN · 2006 to 2026
$28.9M
Epidemiology Research Training for Public Health Impact in Nigeria (Epi-Nigeria)D43TW010051 · FIC · UNIVERSITY OF MARYLAND BALTIMORE · PI ABIMIKU, ALASH'LE G., CHARURAT, MANHATTAN E · 2016 to 2020
$1.5M
FIC NIH HHS D43 TW010051NIA NIH HHS P30 AG028747
6 · The paper itself

Abstract

This study aimed to identify predictors of time to first interruption in treatment (IIT) and predictors of ever being interrupted in ART treatment among PLHIV in Nigeria using a national longitudinal dataset that covers all PEPFAR-funded implementing partners to inform national strategies to prevent IIT. This retrospective cohort study used data from Nigeria's National Data Repository (NDR). The NDR is a de-identified longitudinal database of over 1.9 million PLHIV who received ART in Nigeria beginning in 2004 and is owned by the Federal Ministry of Health (FMoH). The NDR contains patient-level demographics, clinic visits, laboratory, and ART prescription and refill data uploaded at least monthly. The data extracted for this study were obtained from electronic medical record systems of 2,226 public facilities offering HIV care in the country. In this study, we investigated the predictors of treatment interruption using data from the national HIV treatment program. We identified sets of predictors of first interruption in treatment using the logistic regression and these to be consistent in predicting time to first interruption including sex, anchor drug in ART regimen, recorded HIV viral load, recorded CD4 cell count, WHO clinical staging, functional status, last measured weight, highest education attained, occupation, marital status, year enrolled in care, pre and post surge, pre and post-COVID and residing in a state capital, Lagos, or the federal capital territory (FCT) (capital city dweller) versus other locations (non capital city dweller). Age grouping was the only variable that was predictive only for time to first interruption but not for having a first interruption. To reduce the risk of IIT it is important to target interventions preemptively. We have highlighted the need for tailored interventions that address the unique needs of PLHIV in Nigeria. Targeted interventions focusing on those with a combination of risk factors could include education, counseling, supportive services, and monitoring and outreach.

Indexed as

Anti-HIV AgentsHIV InfectionsAdolescentAdultCD4 Lymphocyte CountDatabases, FactualFemaleHumansMaleMiddle AgedNigeriaRetrospective StudiesYoung AdultAnti-HIV Agents

Identifiers

PMID40112252
PMCPMC11925460

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.